Interleukin-8: A critical chemokine in biliary atresia

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 6, 2015, Pages 970-976

  Dong, Rui ^a,b   Zheng, Shan ^a,b  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Biliary atresia; Inflammation; Interleukin 8; Liver fibrosis; Signaling

Indexed keywords

INTERLEUKIN 8; AUTACOID; BIOLOGICAL MARKER; IL8 PROTEIN, HUMAN;

BILE DUCT ATRESIA; BILE DUCT INJURY; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIVER FIBROSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; BILIARY ATRESIA; IMMUNOLOGY; LIVER CIRRHOSIS; METABOLISM; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY;

BILIARY ATRESIA; BIOMARKERS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; LIVER CIRRHOSIS; MOLECULAR TARGETED THERAPY;

EID: 84928308758     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12900     Document Type: Review

References (74)

1. Hartley J, Harnden A, Kelly D. Biliary atresia. BMJ 2010; 340: c2383.
2. Santos JL, Choquette M, Bezerra JA. Cholestatic liver disease in children. Curr. Gastroenterol. Rep. 2010; 12: 30-39.
3. Shen C, Zheng S, Wang W, Xiao XM. Relationship between prognosis of biliary atresia and infection of cytomegalovirus. World J. Pediatr. 2008; 4: 123-126.
4. Nobili V, Marcellini M, Giovannelli L etal. Association of serum interleukin-8 levels with the degree of fibrosis in infants with chronic liver disease. J. Pediatr. Gastroenterol. Nutr. 2004; 39: 540-544.
5. Kobayashi H, Yamataka A, Lane GJ, Miyano T. Levels of circulating antiinflammatory cytokine interleukin-1 receptor antagonist and proinflammatory cytokines at different stages of biliary atresia. J. Pediatr. Surg. 2002; 37: 1038-1041.
6. Mack CL, Tucker RM, Sokol RJ, Kotzin BL. Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin. Immunol. 2005; 115: 200-209.
7. Mack CL, Tucker RM, Sokol RJ etal. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr. Res. 2004; 56: 79-87.
8. Tilg H, Wilmer A, Vogel W etal. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-274.
9. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol. 2003; 24: 25-29.
10. Loria A, Doyle K, Weinstein AA etal. Multiple factors predict physical performance in people with chronic liver disease. Am. J. Phys. Med. Rehabil. 2014; 93: 470-476.
11. Choi SH, Kwon OJ, Park JY etal. Inhibition of tumour angiogenesis and growth by small hairpin HIF-1alpha and IL-8 in hepatocellular carcinoma. Liver Int. 2014; 34: 632-642.
12. Langhans B, Kramer B, Louis M etal. Intrahepatic IL-8 producing Foxp3(+)CD4(+) regulatory T cells and fibrogenesis in chronic hepatitis C. J. Hepatol. 2013; 59: 229-235.
13. Qin X, Deng Y, Liao XC etal. The IL-8 gene polymorphisms and the risk of the hepatitis B virus/infected patients. DNA Cell Biol. 2012; 31: 1125-1130.
14. Tang KH, Ma S, Lee TK etal. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology 2012; 55: 807-820.
15. Zimmermann HW, Seidler S, Gassler N etal. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS ONE 2011; 6: e21381.
16. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 1994; 55: 97-179.
17. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu. Rev. Immunol. 1997; 15: 675-705.
18. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001; 12: 375-391.
19. Ghasemi H, Ghazanfari T, Yaraee R, Faghihzadeh S, Hassan ZM. Roles of IL-8 in ocular inflammations: a review. Ocul. Immunol. Inflamm. 2011; 19: 401-412.
20. Carpagnano GE, Palladino GP, Lacedonia D, Koutelou A, Orlando S, Foschino-Barbaro MP. Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8. BMC Cancer 2011; 11: 226.
21. Bezerra JA, Tiao G, Ryckman FC etal. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002; 360: 1653-1659.
22. Kohsaka T, Yuan ZR, Guo SX etal. The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia. Hepatology 2002; 36: 904-912.
23. Hsieh CS, Huang CC, Huang LT, Tsai YJ, Chou MH, Chuang JH. Glucocorticoid treatment down-regulates chemokine expression of bacterial cholangitis in cholestatic rats. J. Pediatr. Surg. 2004; 39: 10-15.
24. Honsawek S, Chongsrisawat V, Vejchapipat P, Thawornsuk N, Tangkijvanich P, Poovorawan Y. Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters. Pediatr. Surg. Int. 2005; 21: 73-77.
25. Huang YH, Chou MH, Du YY etal. Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab. Invest. 2007; 87: 66-74.
26. Srivastava A. Biliary atresia and inflammation: from pathogenesis to prognosis. Trop. Gastroenterol. 2011; 32: 1-3.
27. El-Faramawy AA, El-Shazly LB, Abbass AA, Ismail HA. Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis. Trop. Gastroenterol. 2011; 32: 50-55.
28. Bessho K, Mourya R, Shivakumar P etal. Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease. Hepatology 2014; 60: 211-223.
29. Dong R, Chen G, Zheng S, Xia HH. Hepatic expression of interleukin 8 in diagnosing biliary atresia. Hepatology 2015; 61: 731-732.
30. Mack CL, Feldman AG, Sokol RJ. Clues to the etiology of bile duct injury in biliary atresia. Semin. Liver Dis. 2012; 32: 307-316.
31. Xiao Y, Zhou Y, Chen Y etal. The expression of epithelial-mesenchymal transition-related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia. Pediatr. Res. 2015; 77: 310-315.
32. Li J, Bessho K, Shivakumar P etal. Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J. Clin. Invest. 2011; 121: 4244-4256.
33. Saxena V, Shivakumar P, Sabla G, Mourya R, Chougnet C, Bezerra JA. Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia. Sci. Transl. Med. 2011; 3: 102ra194.
34. Dong R, Dong K, Wang X, Chen G, Shen C, Zheng S. Interleukin-33 overexpression is associated with gamma-glutamyl transferase in biliary atresia. Cytokine 2013; 61: 433-437.
35. Li J, Razumilava N, Gores GJ etal. Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J. Clin. Invest. 2014; 124: 3241-3251.
36. Wu H, Yang S, Wu X etal. Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice. Biochem. Biophys. Res. Commun. 2014; 450: 110-116.
37. Tanabe T, Shimokawaji T, Kanoh S, Rubin BK. IL-33 stimulates CXCL8/IL-8 secretion in goblet cells but not normally differentiated airway cells. Clin. Exp. Allergy 2014; 44: 540-552.
38. Kashiwakura J, Yanagisawa M, Lee H etal. Interleukin-33 synergistically enhances immune complex-induced tumor necrosis factor alpha and interleukin-8 production in cultured human synovium-derived mast cells. Int. Arch. Allergy Immunol. 2013; 161 (Suppl. 2): 32-36.
39. Meephansan J, Tsuda H, Komine M, Tominaga S, Ohtsuki M. Regulation of IL-33 expression by IFN-gamma and tumor necrosis factor-alpha in normal human epidermal keratinocytes. J. Invest. Dermatol. 2012; 132: 2593-2600.
40. Becker CE, O'Neill LA. Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin. Immunopathol. 2007; 29: 239-248.
41. Schmitz J, Owyang A, Oldham E etal. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490.
42. Lee HC, Chang TY, Yeung CY etal. Association of polymorphisms in the interleukin-18 gene with susceptibility to biliary atresia. J. Pediatr. Gastroenterol. Nutr. 2011; 52: 607-611.
43. Narayanaswamy B, Gonde C, Tredger JM, Hussain M, Vergani D, Davenport M. Serial circulating markers of inflammation in biliary atresia-evolution of the post-operative inflammatory process. Hepatology 2007; 46: 180-187.
44. Urushihara N, Iwagaki H, Yagi T etal. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J. Pediatr. Surg. 2000; 35: 446-449.
45. Alisi A, de Vito R, Monti L, Nobili V. Liver fibrosis in paediatric liver diseases. Best Pract. Res. Clin. Gastroenterol. 2011; 25: 259-268.
46. Haafiz AB. Liver fibrosis in biliary atresia. Expert Rev. Gastroenterol. Hepatol. 2010; 4: 335-343.
47. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009; 374: 1704-1713.
48. Shimoda K, Begum NA, Shibuta K etal. Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology 1998; 28: 108-115.
49. Mahmood S, Sho M, Yasuhara Y etal. Clinical significance of intrahepatic interleukin-8 in chronic hepatitis C patients. Hepatol. Res. 2002; 24: 413-419.
50. Asselah T, Bieche I, Laurendeau I etal. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 2005; 129: 2064-2075.
51. Morland CM, Fear J, McNab G, Joplin R, Adams DH. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc. Assoc. Am. Physicians 1997; 109: 372-382.
52. Isse K, Harada K, Nakanuma Y. IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules. Liver Int. 2007; 27: 672-680.
53. Yokoyama T, Komori A, Nakamura M etal. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int. 2006; 26: 467-476.
54. Morland CM, Fear J, Joplin R, Adams DH. Inflammatory cytokines stimulate human biliary epithelial cells to express interleukin-8 and monocyte chemotactic protein-1. Biochem. Soc. Trans. 1997; 25: 232S.
55. Deng YH, Pu CL, Li YC etal. Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia. Dig. Dis. Sci. 2011; 56: 731-740.
56. Ramm GA, Nair VG, Bridle KR, Shepherd RW, Crawford DH. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am. J. Pathol. 1998; 153: 527-535.
57. Lamireau T, Le Bail B, Boussarie L etal. Expression of collagens type I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy. J. Hepatol. 1999; 31: 248-255.
58. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003; 112: 1776-1784.
59. Clement S, Pascarella S, Conzelmann S, Gonelle-Gispert C, Guilloux K, Negro F. The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8. J. Hepatol. 2010; 52: 635-643.
60. Martin-Vilchez S, Sanz-Cameno P, Rodriguez-Munoz Y etal. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 2008; 47: 1872-1883.
61. Schauer IG, Ressler SJ, Tuxhorn JA, Dang TD, Rowley DR. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 2008; 72: 205-213.
62. Feugate JE, Wong L, Li QJ, Martins-Green M. The CXC chemokine cCAF stimulates precocious deposition of ECM molecules by wound fibroblasts, accelerating development of granulation tissue. BMC Cell Biol. 2002; 3: 13.
63. Dong R, Luo Y, Zheng S. alpha-SMA overexpression associated with increased liver fibrosis in infants with biliary atresia. J. Pediatr. Gastroenterol. Nutr. 2012; 55: 653-656.
64. Tatekawa Y, Nakada A, Nakamura T. Intrahepatic biliary ablation with pure ethanol: an experimental model of biliary atresia. Surg. Today 2013; 43: 661-669.
65. Liu R, Bai J, Xu G etal. Multi-allergen challenge stimulates steriod-resistant airway inflammation via NF-kappaB-mediated IL-8 expression. Inflammation 2013; 36: 845-854.
66. Yu Y, Gong R, Mu Y etal. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2. J. Immunol. 2011; 187: 4844-4860.
67. Tang GJ, Wang HY, Wang JY etal. Novel role of AMP-activated protein kinase signaling in cigarette smoke induction of IL-8 in human lung epithelial cells and lung inflammation in mice. Free Radic. Biol. Med. 2011; 50: 1492-1502.
68. Corti A, Bergamini G, Menegazzi M etal. gamma-Glutamyltransferase catabolism of S-nitrosoglutathione modulates IL-8 expression in cystic fibrosis bronchial epithelial cells. Free Radic. Biol. Med. 2013; 65: 360-370.
69. Gambari R, Borgatti M, Lampronti I etal. Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells. Int. Immunopharmacol. 2012; 13: 308-315.
70. Mizunoe S, Shuto T, Suzuki S etal. Synergism between interleukin (IL)-17 and Toll-like receptor 2 and 4 signals to induce IL-8 expression in cystic fibrosis airway epithelial cells. J. Pharmacol. Sci. 2012; 118: 512-520.
71. Palena C, Hamilton DH, Fernando RI. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Future Oncol. 2012; 8: 713-722.
72. Tang H, Sun Y, Shi Z etal. YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-kappaB pathways, causing bronchial smooth muscle proliferation and migration. J. Immunol. 2013; 190: 438-446.
73. Chai W, Zhang J, Duan Y etal. Pseudomonas pyocyanin stimulates IL-8 expression through MAPK and NF-kappaB pathways in differentiated U937 cells. BMC Microbiol. 2014; 14: 26.
74. Attaur R, Harvey K, Siddiqui RA. Interleukin-8: an autocrine inflammatory mediator. Curr. Pharm. Des. 1999; 5: 241-253.